Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development

被引：0
|
作者：
I. E. H. Kremer
P. J. Jongen
S. M. A. A. Evers
E. L. J. Hoogervorst
W. I. M. Verhagen
M. Hiligsmann
机构：
[1] Maastricht University,Department of Health Services Research, School CAPHRI Care and Public Health Research Institute
[2] MS4 Research Institute,Department of Community and Occupational Medicine
[3] University Medical Centre Groningen,Public Mental Health, Trimbos Institute
[4] Netherlands Institute of Mental Health and Addiction,Department of Neurology
[5] St. Antonius Hospital,Department of Neurology
[6] Canisius Wilhelmina Hospital,undefined
来源：
BMC Medical Informatics and Decision Making | / 21卷
关键词：
Multiple sclerosis; Disease-modifying drugs; Patient decision aid; Prototype development; Shared decision making; Alpha testing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development
    Kremer, I. E. H.
    Jongen, P. J.
    Evers, S. M. A. A.
    Hoogervorst, E. L. J.
    Verhagen, W. I. M.
    Hiligsmann, M.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2021, 21 (01)
  • [2] DEVELOPMENT OF A PATIENT DECISION AID BASED ON MULTI-CRITERIA DECISION ANALYSIS FOR DISEASE-MODIFYING DRUGS FOR MULTIPLE SCLEROSIS
    Kremer, Ingrid
    Jongen, Peter
    Evers, Silvia
    Hoogervorst, Erwin
    Verhagen, Wim
    Hiligsmann, Mickael
    MEDICAL DECISION MAKING, 2020, 40 (05) : E459 - E460
  • [3] Agents based multi-criteria decision-aid
    Alba Amato
    Beniamino Di Martino
    Salvatore Venticinque
    Journal of Ambient Intelligence and Humanized Computing, 2014, 5 : 747 - 758
  • [4] Agents based multi-criteria decision-aid
    Amato, Alba
    Di Martino, Beniamino
    Venticinque, Salvatore
    JOURNAL OF AMBIENT INTELLIGENCE AND HUMANIZED COMPUTING, 2014, 5 (05) : 747 - 758
  • [5] Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs
    Alnaqbi, Khalid A.
    Elezbawy, Baher
    Fasseeh, Ahmad N.
    Bangash, Abdul Rauf
    Elshamy, Amin
    Shendi, Hiba
    Aftab, Mohammed I.
    AlMarshoodi, Mozah
    Gebran, Nicole
    AlDhaheri, Noura
    Fahmy, Sahar A.
    Al Dallal, Sara
    Al Naeem, Waeil
    Abaza, Sherif
    Kalo, Zoltan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [6] Development of a decision aid for patients with multiple sclerosis considering disease modifying drug therapy
    Porter, B
    Giovannoni, G
    Mynors, G
    Miller, DH
    Keenan, E
    Tate, J
    Russell, A
    Thompson, A
    Short, D
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S136 - S136
  • [7] Discontinuation Of Prolonged Disease-modifying Treatments In Multiple Sclerosis: A Difficult Decision
    Tuncer, A.
    Ozen, P. Acar
    Karabudak, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 65 - 65
  • [8] Use of Disease-Modifying Drugs in Multiple Sclerosis
    Wurzius, F. Q.
    Silva, C. B.
    de Vecino, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 102 - 103
  • [9] Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
    Utz, Kathrin S.
    Hoog, Jana
    Wentrup, Andreas
    Berg, Sebastian
    Laemmer, Alexandra
    Jainsch, Britta
    Waschbisch, Anne
    Lee, De-Hyung
    Linker, Ralf A.
    Schenk, Thomas
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (06) : 263 - 275
  • [10] Review on multi-criteria decision analysis aid in sustainable energy decision-making
    Wang, Jiang-Jiang
    Jing, You-Yin
    Zhang, Chun-Fa
    Zhao, Jun-Hong
    RENEWABLE & SUSTAINABLE ENERGY REVIEWS, 2009, 13 (09): : 2263 - 2278
12345